Utilization of psychotropic drugs in Taiwan: An overview of outpatient sector in 2000

Chinese Medical Journal (Taipei)

Volumn 65, Issue 8, 2002, Pages 378-391

  Su, Tung Ping ^a   Chen, Tzeng Ji ^a   Hwang, Shinn Jang ^a   Chou, Li Fang ^a   Fan, Angela P ^a   Chen, Yu Chun ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Defined daily doses (DDDs); Drug utilization; Insurance claims database; Pharmacoepidemiology; Psychotropic drugs

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOPENTHIXOL; DIAZEPAM; ESTAZOLAM; FLUDIAZEPAM; FLUNEPAN; FLUNITRAZEPAM; FLUPENTIXOL; FLUPHENAZINE; FLUPINE; HALOPERIDOL; HYPNOTIC AGENT; LEVOMEPROMAZINE; LORAZEPAM; MODIPANOL; NEUROLEPTIC AGENT; OXAZOLAM; PERPHENAZINE; PIPOTIAZINE; PROCHLORPERAZINE; PSYCHOTROPIC AGENT; SECORIN; SEDATIVE AGENT; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

ACCREDITATION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; DATA BASE; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG USE; DRUG UTILIZATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL DISEASE; MENTAL HEALTH CARE; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PSYCHIATRIST; SEX DIFFERENCE; STANDARDIZATION; TAIWAN; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; TAIWAN;

EID: 0036701784     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jenkins R. Making psychiatric epidemiology useful: the contribution of epidemiology. Acta Psychiatr Scand 2001;103:2-14.
2. Lin TY. A study of incidence of mental disorders in Chinese and other cultures. Psychiatry 1953;16:315-35.
3. Rin H, Lin TY. Mental illness among Formosan aborigines as compared with the Chinese in Taiwan. J Ment Sci 1962;108:134-46.
4. Cheng TA. A pilot study of mental disorders in Taiwan. Psychol Med 1985; 15:195-203.
5. Yeh EK, Hwu HG, Yeh YL. Social changes and prevalences of specific mental disorders in Taiwan. Chin J Mental Health 1987;3:31-42.
6. Hwu HG, Yeh EK, Chang LY, Yeh YL. Psychiatric epidemiology and administration of community psychiatric service: prevalence of specific psychiatric disorders and manpower of community psychiatric service. Chin J Mental Health 1987;3:43-55.
7. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand 1989;79:136-47.
8. Hwu HG, Chang IH, Yeh EK, Chang CJ, Yeh LL. Major depressive disorder in Taiwan defined by the Chinese Diagnostic Interview Schedule. J Nerv Ment Dis 1996; 184:497-502.
9. WHO Expert Committee. The Selection of Essential Drugs (Technical Report Series 615). Geneva: World Health Organization, 1977;615:1-36.
10. Lunde PKM, Baksaas I. Epidemiology of drug utilization-basic concepts and methodology. Acta Med Scand 1988;721 (suppl):7-11.
11. WHO Collaborating Center for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment, 3rd edition. Oslo: 2000.
12. Bergman U, Grimsson A, Wahba AHW, Westerholm B. Studies in Drug Utilization (European series 8). Copenhagen: WHO Regional Office for Europe, 1979.
13. Anonymous. Consumption of drugs: Report on a Symposium, Euro 3102. Copenhagen: WHO Regional Office for Europe, 1970.
14. Baksaas-Aasen I, Lunde PKM, Halse M. Drug Dose Statistics. List of Defined Doses for Drugs Registered in Norway. Oslo: Norwegian Medicinal Depot, 1975.
15. Nordic Council on Medicines. Nordic statistics on medicines 1993-95, NLN publication 43. Uppsala: Nordic Council on Medicines, 1996.
16. Yang J GH, Yang YY. Antidepressants usage among public hospitals in Taiwan. Chinese Psychiatry 1991;3:132-7.
17. Yang JG. Usage of antidepressants in public hospitals in 1984 and 1986 fiscal years in Taiwan. Changgeng Yi Xue Za Zhi 1991;14:117-20.
18. Cheng TA & Hsu M. Sex differences in minor psychiatric morbidity among three aboriginal groups in Taiwan: the effects of lineage. Psychol Med 1993;23:949-56.
19. Liu CY, Wang SJ, Teng EL, Fuh JL, Lin CC, Lin KN, et al. Depressive disorders among older residents in a Chinese rural community. Psychol Med 1997;27:943-9.
20. Kessler RC, McGonagle KA, Swartz M. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. J Affective Disord 1993;29:85-96.
21. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HU. Sex differences in rate of depression: cross national perspectives. J Affective Disord 1993;29:77-84.
22. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
23. Psychotropic Substances., Statistics.for 1999. New York: United Nations, 2001.
24. OECD Health Data 2001. Paris: OECD (Organization for Economic Co-operation and Development), 2001.
25. McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust 2000;173:458-61.
26. Sundquist J, Ekedahl A, Johansson SE. Sales of tranquillizers, hypnotics/sedatives and antidepressants and their relationship with underprivileged area score and mortality and suicide rates. Eur J Clin Pharmacol 1996;51:105-9.
27. Pietraru C, Barbui C, Poggio L, Tognoni G. Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. Eur J Clin Pharmacol 2001,57:605-9.
28. Compton WM, Helzer JE, Hwu HG, Yeh EK, McEvoy L, Tipp JE, Spitznagel EL. New methods in cross-cultural psychiatry: psychiatric illness in Taiwan and the United States. Am J Psychiatry 1991; 148:1697-704.
29. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-9.
30. Lépine JP. Epidemiology, burden, and disability in depression and anxiety. J Clin Psychiatry 2001;62(suppl 13):4-10.
31. Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, Zito JM. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998;279:526-31.
32. Strom BL. What is pharmacoepidemiology? In: Strom BL, ed. Pharmacoepidemiology, 3rd ed. Chichester, New York, Weinheim: John Wiley & Sons, 2000:3-15.
33. Schiff GD, Rucker TD. Computerized prescribing: building the electronic infrastructure for better usage. JAMA 1998; 279:1024-9.
34. Fox MH, Foster CH, Zito JM. Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in Medicaid. Am J Med Qual 2000;15:126-36.